Glenmede Trust’s GenMark Diagnostics, Inc GNMK Stock Holding History

Glenmede Trust’s Portfolio GNMK Stock Details GNMK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-24	Closed	–	–	2531
2020 Q3	$0	Hold	24	–	–	﹤0.01%	2650
2020 Q2	$0	Hold	24	–	–	﹤0.01%	2708
2020 Q1	$0	Hold	24	–	–	﹤0.01%	3092
2019 Q4	$0	Sell	24 -1,000	-98%	-$5.52K	﹤0.01%	3180
2019 Q3	$6	Hold	1,024	–	–	﹤0.01%	2590
2019 Q2	$6	Hold	1,024	–	–	﹤0.01%	2591
2019 Q1	$7	Hold	1,024	–	–	﹤0.01%	2514
2018 Q4	$4	Buy	+1,024	New	+$5.33K	﹤0.01%	2628
2018 Q2	–	Sell	-1,000	Closed	-$4K	–	2425
2018 Q1	$4K	Hold	1,000	–	–	﹤0.01%	2485
2017 Q4	$4K	Hold	1,000	–	–	﹤0.01%	2485
2017 Q3	$9K	Hold	1,000	–	–	﹤0.01%	2218
2017 Q2	$12K	Hold	1,000	–	–	﹤0.01%	2075
2017 Q1	$12K	Hold	1,000	–	–	﹤0.01%	2075
2016 Q4	$12K	Sell	1,000 -103	-9%	-$1.22K	﹤0.01%	2070
2016 Q3	$13K	Buy	1,103 +103	+10%	+$994	﹤0.01%	2074
2016 Q2	$8K	Hold	1,000	–	–	﹤0.01%	2157
2016 Q1	$5K	Hold	1,000	–	–	﹤0.01%	2228
2015 Q4	$7K	Hold	1,000	–	–	﹤0.01%	2181
2015 Q3	$7K	Hold	1,000	–	–	﹤0.01%	2213
2015 Q2	$9K	Hold	1,000	–	–	﹤0.01%	2129
2015 Q1	$12K	Hold	1,000	–	–	﹤0.01%	2094
2014 Q4	$13K	Hold	1,000	–	–	﹤0.01%	2156
2014 Q3	$8K	Hold	1,000	–	–	﹤0.01%	2165
2014 Q2	$13K	Hold	1,000	–	–	﹤0.01%	1996
2014 Q1	$9K	Hold	1,000	–	–	﹤0.01%	2063
2013 Q4	$13K	Hold	1,000	–	–	﹤0.01%	1933
2013 Q3	$12K	Hold	1,000	–	–	﹤0.01%	1897
2013 Q2	$10K	Buy	+1,000	New	+$13.8K	﹤0.01%	1879

Other funds holding GNMK

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

CCM

Consonance Capital Management New York $7.28M AUM 43.59% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return

Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Glenmede Trust's GNMK Position: Q4 2020 in Review

Glenmede Trust sold out of GenMark Diagnostics, Inc (GNMK) in Q4 2020, closing a stake of 24 shares.

Glenmede Trust first reported a position in GNMK in Q2 2013 and held it in 28 quarters. The position peaked at $13K in Q3 2016. 151 funds tracked by Wall St. Rank hold GNMK as of Q4 2020.

Glenmede Trust reported no remaining GenMark Diagnostics, Inc position as of Q4 2020 after selling out during the quarter.
Glenmede Trust sold 24 GenMark Diagnostics, Inc shares in Q4 2020.
Glenmede Trust first reported a position in GenMark Diagnostics, Inc in Q2 2013 and held it in 28 quarters.
Glenmede Trust's GenMark Diagnostics, Inc position peaked at $13K in Q3 2016.
151 funds tracked by Wall St. Rank held GenMark Diagnostics, Inc as of Q4 2020.

Based on Glenmede Trust's 13F filing for Q4 2020, filed 16 Feb 2021.